Skip to main content
Premium Trial:

Request an Annual Quote

The Money Pours In

At the annual Indian Science Congress this week, India's Prime Minister Manmohan Singh promised his country's researchers more funding for their work, says ScienceInsider's Pallava Bagla. "Singh said he will seek to boost R&D expenditures to at least 2 percent of gross domestic product by 2017, up from the current 0.9 percent," Bagla reports. "According to his target, over the next five years R&D spending would rise to about $8 billion per year, up from $3 billion spent in 2011. He also unveiled plans for a $1 billion supercomputing center at the Indian Institute of Science in Bangalore and a $270 million underground Indian Neutrino Observatory in Theni."

Singh told conference attendees that while he is glad to see the number of scientific publications from Indian researchers steadily rising, he still thinks India isn't keeping up with other nations. "Singh signaled that much of the new government spending will go to engineering and applied sciences," Bagla adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.